25Jan 2025
GLP-1 RA Therapy Shows Limited HbA1c and Weight Benefits

GLP-1 RA Therapy Shows Limited HbA1c and Weight Benefits

The study assessed HbA1c and weight changes after six months of once-weekly GLP-1 RA therapy in UK primary care. Among 10,816 adults with T2D, 32.8% achieved HbA1c <7%, with better outcomes for shorter T2D duration. Of 3963 with weight data, 17.0% achieved ≥10% weight loss. Two-thirds did not meet HbA1c targets, highlighting the need for improved diabetes management in primary care.

  • #endo-diabetology

Like

Save

Share